BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 1752781)

  • 1. Summation effects of uracil and other promoters on epithelial lesion development in the F344 rat urinary bladder initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    de Camargo JL; Shirai T; Kato T; Asamoto M; Fukushima S
    Jpn J Cancer Res; 1991 Nov; 82(11):1220-5. PubMed ID: 1752781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Summation effect of uracil on the two-stage and multistage models of urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Masui T; Shirai T; Takahashi S; Mutai M; Fukushima S
    Carcinogenesis; 1988 Nov; 9(11):1981-5. PubMed ID: 3180336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoting activities of butylated hydroxyanisole and butylated hydroxytoluene on 2-stage urinary bladder carcinogenesis and inhibition of gamma-glutamyl transpeptidase-positive foci development in the liver of rats.
    Imaida K; Fukushima S; Shirai T; Ohtani M; Nakanishi K; Ito N
    Carcinogenesis; 1983; 4(7):895-9. PubMed ID: 6135514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent effects of butylated hydroxyanisole, butylated hydroxytoluene and ethoxyquin for promotion of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
    Fukushima S; Ogiso T; Kurata Y; Hirose M; Ito N
    Cancer Lett; 1987 Jan; 34(1):83-90. PubMed ID: 3802071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in cell proliferation and apoptosis between reversible and irreversible mucosal lesions associated with uracil-induced urolithiasis in N-butyl-N-(4-hydroxybutyl)nitrosamine-pretreated.
    Shirai T; Shibata M; Takahashi S; Tagawa Y; Imaida K; Hirose M
    Carcinogenesis; 1995 Mar; 16(3):501-5. PubMed ID: 7697805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promotion by ascorbic acid, sodium erythorbate and ethoxyquin of neoplastic lesions in rats initiated with N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Fukushima S; Kurata Y; Shibata M; Ikawa E; Ito N
    Cancer Lett; 1984 May; 23(1):29-37. PubMed ID: 6744233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term screening of promoters of bladder carcinogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats.
    Miyata Y; Fukushima S; Hirose M; Masui T; Ito N
    Jpn J Cancer Res; 1985 Sep; 76(9):828-34. PubMed ID: 3932281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis.
    Ito N; Fukushima S; Shirai T; Hagiwara A; Imaida K
    IARC Sci Publ; 1984; (56):399-407. PubMed ID: 6536604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of uracil calculi on cell growth and apoptosis in the BBN-initiated Wistar rat urinary bladder mucosa.
    Vieira de Oliveira S; Viana de Camargo JL; Cardoso PR; Padovani CR; Fukushima S
    Teratog Carcinog Mutagen; 1999; 19(4):293-303. PubMed ID: 10406893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of 1,3-diaminopropane, an ornithine decarboxylase inhibitor, on rat two-stage urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Salim EI; Wanibuchi H; Morimura K; Kim S; Yano Y; Yamamoto S; Fukushima S
    Carcinogenesis; 2000 Feb; 21(2):195-203. PubMed ID: 10657958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promoting effect of the peroxisome proliferator, clofibrate, but not di(2-ethylhexyl)phthalate, on urinary bladder carcinogenesis in F344 rats initiated by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Hagiwara A; Tamano S; Ogiso T; Asakawa E; Fukushima S
    Jpn J Cancer Res; 1990 Dec; 81(12):1232-8. PubMed ID: 2125992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promotion by sodium L-ascorbate in rat two-stage urinary bladder carcinogenesis is dependent on the interval of administration.
    Chen TX; Wanibuchi H; Murai T; Kitano M; Yamamoto S; Fukushima S
    Jpn J Cancer Res; 1999 Jan; 90(1):16-22. PubMed ID: 10076560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kitahori Y; Konishi N; Shimoyama T; Hiasa Y
    Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of promoting potential of bracken fern (Pteridium aquilinum) in rat urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)-nitrosamine and uracil.
    de Oliveira ML; Souza Rocha N; Fukushima S; de Camargo JL
    Teratog Carcinog Mutagen; 1995; 15(4):191-9. PubMed ID: 8838633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of synergism in rat urinary tract carcinogenesis between prior uracil treatment and N-butyl-N-(4-hydroxybutyl)-nitrosamine administration.
    Okumura M; Shirai T; Asamoto M; Ogiso T; Fukushima S
    Cancer Lett; 1991 Jun; 58(1-2):81-5. PubMed ID: 2049787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of heterozygosity in (LewisxF344)F1 rat urinary bladder tumors induced with N-butyl-N-(4-hydroxybutyl)nitrosamine followed by dimethylarsinic acid or sodium L-ascorbate.
    Chen T; Na Y; Wanibuchi H; Yamamoto S; Lee CC; Fukushima S
    Jpn J Cancer Res; 1999 Aug; 90(8):818-23. PubMed ID: 10543252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of promotion of N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated urinary bladder carcinogenesis in mice by rat cancer promoters.
    Tamano S; Asakawa E; Boomyaphiphat P; Masui T; Fukushima S
    Teratog Carcinog Mutagen; 1993; 13(2):89-96. PubMed ID: 8102212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects of L-ascorbic acid, citric acid or their sodium salts on tumor induction by N-butyl-N-(4-hydroxybutyl)nitrosamine or N-ethyl-N-(4-hydroxybutyl)nitrosamine in the rat urinary bladder.
    Inoue T; Imaida K; Suzuki E; Okada M; Fukushima S
    Cancer Lett; 1988 Jun; 40(3):265-73. PubMed ID: 3383181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-ascorbic acid amplification of bladder carcinogenesis promotion by K2CO3.
    Fukushima S; Kurata Y; Hasegawa R; Asamoto M; Shibata MA; Tamano S
    Cancer Res; 1991 May; 51(10):2548-51. PubMed ID: 2021935
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoting effects of various chemicals in rat urinary bladder carcinogenesis initiated by N-nitroso-n-butyl-(4-hydroxybutyl)amine.
    Fukushima S; Hagiwara A; Ogiso T; Shibata M; Ito N
    Food Chem Toxicol; 1983 Feb; 21(1):59-68. PubMed ID: 6681793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.